MedPath

Effect of hemp seed oil on clinical symptoms in patients with Knee osteoarthritis referred to the Rheumatology Clinic of Rafsanjan in 2022: A randomized, double-blind, control trial

Phase 3
Conditions
osteoarthritis.
Osteoarthritis of knee
Registration Number
IRCT20180811040759N2
Lead Sponsor
Rafsanjan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

Age of 45-70 years
The diagnosis of osteoarthritis of the knee according to the criteria of the American College of Rheumatology, which is confirmed by a specialist in hematology
The presence of moderate knee pain within 24 hours based on linear-visual pain scale (VAS) between 4 7 cm
Completing the informed consent form

Exclusion Criteria

Patients with inflammatory diseases (such as lupus, rheumatoid arthritis, history of brucellosis, etc.)
Cancer or chronic diseases
Symptoms or history of liver or kidney failure
Oral corticosteroid consumption during the past 4 weeks
Corticosteroid injection in the last 6 months fever
Consumption of medical herbs continuously
Smoking and drug abuse
Allergy to hemp seed oil
Observe any side effects that the patient thinks are caused by the oil
use of food and drug supplements
Oral use of other analgesics regularly and advanced disease
Use of other topical medications at the site of drug administration
Skin or infectious disease or ulcers at the site of pregnancy medication
Reluctance to continue participating in the study
Failure to comply with the study protocol

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Knee pain intensity. Timepoint: At the beginning and the end of the study (two months after the beginning of the study). Method of measurement: Visual Analogue Scale (VAS) And WOMAC index.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath